Robert Mashal - 08 Oct 2024 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Oct 2024, 16:33:51 UTC
Prior SEC filing
10 Jan 2024
Next SEC filing
03 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ron A. Metzger, Attorney-in-Fact

Key filing fact

Robert Mashal filed Form 4 for Nuvation Bio Inc. (NUVB) on 10 Oct 2024.

Key facts

  • This page summarizes Robert Mashal's Form 4 filing for Nuvation Bio Inc. (NUVB).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 10 Oct 2024, 16:33.

Change

  • Previous filing in this sequence was filed on 10 Jan 2024.
  • Current net transaction value: +$220,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Purchase

Transaction value
$41.7
Shares
+19
Change %
Price
$2.20
Shares after
19
Date
08 Oct 2024
Ownership
By Trust
Footnotes
F1
NUVB transaction

Class A Common Stock

Purchase

Transaction value
$219,958
Shares
+99,981
Change %
+526216%
Price
$2.20
Shares after
100,000
Date
08 Oct 2024
Ownership
By Trust
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .